ASCO
-
ASCO 2022
1.Prof.Pan Jing made two posters display with the theme of"Updated efficacy and safety report of a phase I trial of donor-derived CD7 CAR-T cells for T-cell acute lymphoblastic leukemia"and"Phase I study of donor-derived CD5 CAR-T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukemia".
-
ASCO 2021
Prof.Pan Jing's"Donor-derived CD7 CAR-T cells for T-cell acute lymphoblastic leukemia"study was selected for oral presentation at the conference,and the study was selected as the highlight summary of the ASCO annual meeting.
